ASPG and T-cell non-Hodgkin lymphoma: In an effort to improve outcome, CCRT followed by an L-asparaginase-containing regimen (VIDL, etoposide, ifosfamide, dexamethasone, L-asparaginase) was tested in 30 patients with stage I/II NK/T-cell lymphoma [64].